Carisma Therapeutics Stock Today
| CARM Stock | 1.70 0.17 9.09% |
Performance0 of 100
| Odds Of DistressLess than 28
|
Carisma Therapeutics is selling at 1.70 as of the 24th of April 2024; that is -9.09 percent decrease since the beginning of the trading day. The stock's lowest day price was 1.68. Carisma Therapeutics has about a 28 % chance of experiencing some form of financial distress in the next two years of operation but has generated negative returns over the last 90 days. Equity ratings for Carisma Therapeutics are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 24th of February 2024 and ending today, the 24th of April 2024. Click here to learn more.
Moving together with Carisma Stock
| 0.67 | VAXX | Vaxxinity Financial Report 14th of May 2024 | PairCorr |
Moving against Carisma Stock
| 0.7 | VALN | Valneva SE ADR Financial Report 2nd of May 2024 | PairCorr |
| 0.69 | DOMH | Dominari Holdings | PairCorr |
| 0.53 | VERU | Veru Inc Financial Report 9th of May 2024 | PairCorr |
| 0.49 | YS | YS Biopharma | PairCorr |
Follow Valuation Odds of Bankruptcy
Financial Report 9th of May 2024
Carisma Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Carisma Therapeutics' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Carisma Therapeutics or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO President | Steven Kelly |
| Business Concentration | Pharmaceutical Products, Biotechnology, Healthcare, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) |
Carisma Therapeutics (CARM) is traded on NASDAQ Exchange in USA. It is located in 3675 Market Street, Philadelphia, PA, United States, 19104 and employs 107 people. Carisma Therapeutics is listed under Pharmaceutical Products category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 73.95 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Carisma Therapeutics's market, we take the total number of its shares issued and multiply it by Carisma Therapeutics's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Carisma Therapeutics conducts business under Biotechnology sector and is part of Health Care industry. The entity has 41.54 M outstanding shares of which 1.58 M shares are currently shorted by private and institutional investors with about 9.65 trading days to cover.
Carisma Therapeutics generates negative cash flow from operations
Check Carisma Therapeutics Probability Of Bankruptcy
Ownership AllocationCarisma Therapeutics holds a total of 41.54 Million outstanding shares. Carisma Therapeutics retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Carisma Ownership Details
Carisma Stock Price Odds Analysis
Contingent on a normal probability distribution, the odds of Carisma Therapeutics jumping above the current price in 90 days from now is roughly 96.0%. The Carisma Therapeutics probability density function shows the probability of Carisma Therapeutics stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days Carisma Therapeutics has a beta of 0.5541 suggesting as returns on the market go up, Carisma Therapeutics average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Carisma Therapeutics will be expected to be much smaller as well. Additionally, carisma Therapeutics has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
Based on a normal probability distribution, the odds of Carisma Therapeutics to move above the current price in 90 days from now is roughly 96.0 (This Carisma Therapeutics probability density function shows the probability of Carisma Stock to fall within a particular range of prices over 90 days) .
Carisma Therapeutics Risk Profiles
Investors will always prefer to have the highest possible return on investment while minimizing volatility. Carisma Therapeutics market risk premium is the additional return an investor will receive from holding Carisma Therapeutics long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Carisma Therapeutics. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Although Carisma Therapeutics' alpha and beta are two of the key measurements used to evaluate Carisma Therapeutics' performance over the market, the standard measures of volatility play an important role as well.
| Risk Adjusted Performance | (0.03) | |||
| Jensen Alpha | (0.35) | |||
| Total Risk Alpha | (0.99) | |||
| Treynor Ratio | (0.54) |
Carisma Stock Against Markets
Picking the right benchmark for Carisma Therapeutics stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Carisma Therapeutics stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Carisma Therapeutics is critical whether you are bullish or bearish towards Carisma Therapeutics at a given time. Please also check how Carisma Therapeutics' historical prices are related to one of the top price index indicators.
Be your own money manager
Our tools can tell you how much better you can do entering a position in Carisma Therapeutics without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Sync Your Broker Now
Sync Your BrokerSync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |
| All Next | Launch Module |
Carisma Therapeutics Corporate Executives
Elected by the shareholders, the Carisma Therapeutics' board of directors comprises two types of representatives: Carisma Therapeutics inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Carisma. The board's role is to monitor Carisma Therapeutics' management team and ensure that shareholders' interests are well served. Carisma Therapeutics' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Carisma Therapeutics' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Klichinsky PharmD | CoFounder Officer | Profile | |
| Saar MD | CoFounder | Profile | |
| Richard CPA | Chief CFO | Profile |
How to buy Carisma Stock?
Before investing in Carisma Therapeutics, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Carisma Therapeutics. To buy Carisma Therapeutics stock, you can follow these steps:- Choose a brokerage firm: You need to select a brokerage firm to buy shares of Carisma Therapeutics. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
- Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
- Fund your account: You will need to deposit funds into your brokerage account to purchase Carisma Therapeutics stock. You can do this by transferring funds from your bank account or other investment accounts.
- Place your order: Once you have located Carisma Therapeutics stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
- Monitor your investment: After you have purchased Carisma Therapeutics stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Carisma Therapeutics, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Carisma Stock please use our How to Invest in Carisma Therapeutics guide.
Already Invested in Carisma Therapeutics?
The danger of trading Carisma Therapeutics is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Carisma Therapeutics is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Carisma Therapeutics. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Carisma Therapeutics is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Carisma Therapeutics is a strong investment it is important to analyze Carisma Therapeutics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Carisma Therapeutics' future performance. For an informed investment choice regarding Carisma Stock, refer to the following important reports: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Carisma Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. To learn how to invest in Carisma Stock, please use our How to Invest in Carisma Therapeutics guide.You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Complementary Tools for Carisma Stock analysis
When running Carisma Therapeutics' price analysis, check to measure Carisma Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Carisma Therapeutics is operating at the current time. Most of Carisma Therapeutics' value examination focuses on studying past and present price action to predict the probability of Carisma Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Carisma Therapeutics' price. Additionally, you may evaluate how the addition of Carisma Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |
Is Carisma Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Carisma Therapeutics. If investors know Carisma will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Carisma Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Carisma Therapeutics is measured differently than its book value, which is the value of Carisma that is recorded on the company's balance sheet. Investors also form their own opinion of Carisma Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Carisma Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Carisma Therapeutics' market value can be influenced by many factors that don't directly affect Carisma Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Carisma Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Carisma Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Carisma Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.